Genotyping of factor V G1691a (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes

Clinical Chemistry

Volumn 46, Issue 8 I, 2000, Pages 1051-1056

  Hessner, M J ^a   Budish, M A ^a   Friedman, K D ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; RESTRICTION ENDONUCLEASE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA TEMPLATE; GEL ELECTROPHORESIS; GENE MUTATION; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; TEMPERATURE DEPENDENCE;

EID: 0033869814     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.8.1051     Document Type: Article

References (30)

1. Familial thrombophilia due to a previously unrecognized mechanism characterized by a poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
2. Resistance to activated protein C as a basis for venous thrombosis
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. Characterization of the molecular defect in FV R506Q
5. Structure of the gene for human coagulation factor V
6. Complete cDNA and derived amino acid sequence of human factor V
7. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis
8. High risk of thrombosis in patients homozygous for factor V Leiden (APC resistance)
9. Risk factors for venous thrombotic disease
10. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes
11. Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay
12. A comparison of eubacterial and archaeal structure-specific 5'-exonucleases
13. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance
14. Improved method for factor V Leiden typing by PCR-SSP
15. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and 5,10-methylene tetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR
16. World distribution of factor V Leiden
17. The population genetics of factor V Leiden (Arg506GIn)
18. 1,2 genotyping by multiplexed allele-specific PCR
19. Genotyping of Kel1 and Kel2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers (PCR-SSP)
20. Determination of neutrophil antigen NA gene frequencies in five different ethnic groups by polymerase chain reaction with sequence specific primers (PCR-SSP)
21. Prenatal genotyping of the Duffy blood group system by allele-specific polymerase chain reaction
22. b of the human Kidd blood group system by allele-specific polymerase chain reaction
23. Allelic distribution of the glycoprotein 1a (α2-integrin) C807T/G873A dimorphisms among Caucasian venous thrombosis patients and six racial groups
24. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
25. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
26. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
27. Contribution of the glycoprotein la 807TT, methylene tetrahydrofolate reductase 677TT, and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Leiden) carriers
28. The prothrombin 20210A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia
29. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation
30. The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg to Gln mutation but not with protein S deficiency in thrombophilic families